Cross-Sector entity

American Society of Plastic Surgeons

organization
5

market-trends is the sole category represented across all 1 tracked stories. American Society of Plastic Surgeons is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention American Society of Plastic Surgeons, all published on March 4, 2026.

1 verified story tracked

Last mentioned: Mar 4, 2026

Entity pulse

Recent coverage · American Society of Plastic Surgeons

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about American Society of Plastic Surgeons

market-trends is the sole category represented across all 1 tracked stories. American Society of Plastic Surgeons is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention American Society of Plastic Surgeons, all published on March 4, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering American Society of Plastic Surgeons. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Aesthetic Market Realignment

    Dermal filler and plastic surgery volumes hit record highs as patients seek to correct skin laxity post-weight loss.

  2. Telehealth Pivot

    Major digital health platforms launch dedicated GLP-1 programs with compounded options to address shortages.

  3. The 'Ozempic Face' Viral Trend

    Social media and news outlets begin highlighting the aesthetic side effects of rapid weight loss.

  4. Wegovy Launch

    FDA approves semaglutide specifically for chronic weight management, sparking mainstream interest.

  5. Ozempic Approval

    FDA approves semaglutide for Type 2 diabetes, marking the start of the GLP-1 era.

Stories mentioning American Society of Plastic Surgeons 1